CA2404421A1 - Reagent systems for detecting the presence of a reduced cofactor in a sample and methods for using the same - Google Patents
Reagent systems for detecting the presence of a reduced cofactor in a sample and methods for using the same Download PDFInfo
- Publication number
- CA2404421A1 CA2404421A1 CA002404421A CA2404421A CA2404421A1 CA 2404421 A1 CA2404421 A1 CA 2404421A1 CA 002404421 A CA002404421 A CA 002404421A CA 2404421 A CA2404421 A CA 2404421A CA 2404421 A1 CA2404421 A1 CA 2404421A1
- Authority
- CA
- Canada
- Prior art keywords
- signal producing
- electron transfer
- reagent
- transfer agent
- analyte
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/90212—Oxidoreductases (1.) acting on a sulfur group of donors (1.8)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Signal producing systems, reagent compositions, test strips and kits of the same, as well as methods for their use in the detection of an analyte in a sample, are provided. The subject signal producing systems are characterized by having at least a first and second electron transfer agent and a redox indicator, where in many preferred embodiments the systems include a proteinaceous and non-proteinaceous electron transfer agent, e.g. a phenazin e compound and a diaphorase. In many preferred embodiments, the subject system s and kits further include at least one of and often both of an enzyme cofacto r and an enzyme having an analyte oxidizing activity, e.g. an analyte dehydrogenase. The subject systems, reagent compositions, test strips and ki ts find use in the detection of a wide variety of analytes in a sample, such as a physiological sample, e.g. blood or a fraction thereof.
Description
REAGENT SYSTEMS FOR DETECTING THE PRESENCE OF A REDUCED
COFACTOR IN A SAMPLE AND METHODS FOR USING THE SAME
INTRODUCTION
Field of the Invention The field of this invention is analyte detection, particularly reagent systems for use in analyte detection.
Back round of the Invention 1o Analyte detection in physiological fluids, e.g. blood or blood derived products, is of ever increasing importance to today's society. Analyte detection assays find use in a variety of applications, including clinical laboratory testing, home testing, etc., where the results of such testing play a prominent role in diagnosis and management in a variety of disease conditions. Analytes of interest include alcohol, formaldehyde, glucose, glutamic acid, 15 glycerol, beta-hydroxybutyrate, L-lactate, leucine, malic acid, pyruvic acid, steroids, etc. In response to this growing importance of analyte detection, a variety of analyte detection protocols and devices for both clinical and home use have been developed. Many of the protocols and devices that have been developed to date employ a signal producing system to identify the presence of the analyte of interest in a physiological sample, such as blood.
2o One type of signal producing system that finds use in the detection of a variety of different analytes is one in which a dehydrogenase oxidizes the analyte of interest and concomitantly reduces an enzyme cofactor, such as NAD(P)+. The reduced form of the cofactor, e.g. NAD(P)H, is then detected through subsequent reaction with a cofactor oxidizing agent, e.g. phenazine methosulfate or a diaphorase, that transfers an electron to a 25 redox indicator, such as a tetrazolium salt, to produce a detectable product.
While a variety of such signal producing systems have been developed to date for use in the detection of a wide variety of different analytes, there continues to be a need for the fi~rther development of such systems. For example, a signal producing system which provided for an enhanced reaction rate and a lower cost would be of great interest.
3o Relevant Literature U.S. Patents of interest include: 4,629,697; 5,126,247 and 5,902,731. See also Raap et al., Histochem. J. (1983) 15:881-893.
SUMMARY OF THE INVENTION
Signal producing systems, reagent compositions, test strips and kits of the same, as well as methods for their use in the detection of an analyte in a sample, are provided. The subject signal producing systems are characterized by having at least a first and second electron transfer agent and a redox indicator, where in many preferred embodiments the systems include a proteinaceous and non-proteinaceous electron transfer agent, e.g. a phenazine compound and a diaphorase. In many preferred embodiments, the subject systems and kits further include both an enzyme cofactor and an enzyme having an analyte oxidizing activity, e.g. an analyte dehydrogenase. The subject systems, reagent compositions, test 1o strips and kits find use in the detection of a wide variety of analytes in a sample, such as a physiological sample, e.g. blood or a fraction thereof.
BRIEF DESCRIPTION OF THE FIGURES
Fig. 1 provides a graphical representation of the observed rate of reaction in a test strip according to the subject invention vs. the theoretical expected rate of reaction for a test strip that includes both PMS and a diaphorase, clearly demonstrating that the use of both a non-proteinaceous and proteinaceous electron transfer agent, e.g. PMS and a diaphorase, provides for an unexpected increase in the rate of reaction.
2o DESCRIPTION OF THE SPECIFIC EMBODIMENTS
Signal producing systems, reagent compositions, test strips and kits of the same, as well as methods for their use in the detection of an analyte in a sample, are provided. The subject signal producing systems are characterized by having at least a first and second electron transfer agent and a redox indicator, where in many preferred embodiments the systems include a proteinaceous and non-proteinaceous electron transfer agent, e.g. a phenazine compound and a diaphorase. In many preferred embodiments, the subject systems and kits further include both an enzyme cofactor and an enzyme having an analyte oxidizing activity, e.g. an analyte dehydrogenase. The subject systems, reagent compositions, test strips and kits find use in the detection of a wide variety of analytes in a sample, such as a 3o physiological sample, e.g. blood or a fraction thereof.
Before the subject invention is described further, it is to be understood that the invention is not limited to the particular embodiments of the invention described below, as variations of the particular embodiments may be made and still fall within the scope of the appended claims. It is also to be understood that the terminology employed is for the purpose of describing particular embodiments, and is not intended to be limiting.
Instead, the scope of the present invention will be established by the appended claims.
In this specification and the appended claims, singular references include the plural, unless the context clearly dictates otherwise. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood to one of ordinary skill in the art to which this invention belongs.
/o SIGNAL PRODUCING SYSTEMS
As summarized above, the subject invention provides a signal producing system that is capable of detecting the presence of a reduced enzyme cofactor in a sample.
By signal producing system is meant a collection of two or more compounds or molecules which are 15 capable of acting in concert, when combined, to produce a detectable signal that is indicative of the presence of, and often amount of, a particular analyte in a given sample. The term signal producing system is used broadly to encompass both a mixture of all of the reagent constituents of the signal producing system as well as a system in which one or more of the reagent constituents are separated from the remainder of the reagent constituents, e.g. as is 2o present in a kit.
A feature of the subject signal producing systems is the presence of two distinct electron transfer agents. By electron transfer agent is meant a compound or molecule that can transfer an electron, in the form of a hydride ion, from a reduced enzyme cofactor to a redox indicator. In the subject signal producing systems, the first of the distinct electron 25 transfer agents is a low molecular weight molecule, while the second electron transfer agent is a high molecular weight molecule. In this specification, low molecular weight means a molecular weight that does not exceed about 2000 daltons, usually about 1000 daltons and in many embodiments about 500 daltons. High molecular weight means a molecular weight of at least about 5000 daltons and in many embodiments 10,000 or 20,000 daltons or higher.
3o The molecular weight of the high molecular weight electron transfer agent often will not exceed about 100,000 daltons. In many embodiments, the low molecular weight electron transfer agent is a non-proteinaceous compound while the high molecular weight electron transfer agent is a proteinaceous compound. By proteinaceous is meant a polypeptide or polymeric mimetic thereof.
A variety of low molecular weight non-proteinaceous electron transfer agents are of interest. These agents include: flavins such as riboflavin (RBF), alloxazine s (ALL) and lumichrome (LC); phenazines such as phenazine, phenazine methosulfate (PMS), phenazine ethosulfate, methoxyphenazine methosulfate and safranine; methyl-1, 4-naphthol (menadione), phenothiazines such as PT and its radical cation, PT+, thionin (TH), azure A
(AA), azure B (AB), azure C (AC), methylene blue (MB), methylene green (MG) and toluidine blue O (TOL); phenoxazines such as phenoxazine (POA), basic blue 3 (BB3), and to brilliant cresyl blue ALD (BCBA), benzo-oc-phenazoxonium chloride (Medola's blue);
Indophenols such as 2,6-dichlorophenol indophenol (DCIP); and Indamines such as Bindschedler's green and phenylene blue; and the like.: Of particular interest in many embodiments are phenazine compounds, e.g. PMS, phenazine ethosulfate, methoxyphenazine methosulfate and safranine, where PMS is the low molecular weight, is non-proteinaceous electron transfer agent in many embodiments.
In many embodiments, the high molecular weight proteinaceous electron transfer agent is an enzyme that is capable of oxidizing a reduced cofactor, e.g.
NAD(P)H, and concomitantly reducing a redox indicator. In many embodiments, this electron transfer enzyme is a diaphorase, such as lipoic dehydrogenase, ferredoxin-NADP
reductase, 20 lipoamide dehydrogenase, NADPH dehydrogenase, etc. A variety of diaphoreses are available and may be employed, where representative commercially available diaphoreses that may be present in the subject signal producing systems include bacillus diaphorase, clostridium diaphorase, vibrio diaphorase, porcine diaphorase, and the like.
In the subject signal producing systems, the ratio of the first to the second electron 25 transfer agent is chosen to provide for an accelerated reaction rate as compared to a control, e.g. a comparable signal producing system with a single electron transfer agent, e.g. only PMS or a diaphorase. Typically, the ratio of the first to the second electron transfer agent in the subject systems ranges from about 0.001 to 10, usually from about 0.01 to 1.0 and more usually from about 0.05 to 0.5 (nmole/U), respectively.
3o In addition to the above described first and second electron transfer agents, the subject signal producing systems also include a redox indicator. By redox indicator is meant a compound that is capable of being reduced by the electron transfer agents to produce a detectable, e.g. chromogenic, product. Where the redox indicator produces a chromogenic product, i.e. the redox indicator is a chromogen, suitable chromogens are any compound capable of changing color upon reduction by one or more electrons, where suitable chromogens are generally ones that accept electrons from the electron transfer agents, described above.
A variety of different redox indicator compounds are of interest. Compounds of interest include: oxazines, thiazines, and tetrazolium salts. Of particular interest in many embodiments are tetrazolium salts which are capable of accepting the captured hydride from the electron transfer agents to form a colored formazan product. In many embodiments, these salts have the advantageous feature of being faint yellow in the oxidized form, but turn to bright visible colors upon electron reduction and conversion to formazan dyes. Tetrazolium compounds or salts that are of particular interest include: 2-(2' benzothiazolyl)-5-styryl-3-(4'-phthalhydrazidyl) tetrazolium (BSPT); 2-benzothiazolyl-(2)-3,5-diphenyl tetrazolium (BTDP); 2,3-di(4-nitrophenyl) tetrazolium (DNP); 2,5-diphenyl-3-(4-styrylphenyl) tetrazolium (DPSP); distyryl nitroblue tetrazolium (DS-NBT); 3,3'-[3,3'-dimethoxy-(1,1'-15 biphenyl)-4,4'-diyl]-bis[2-(4-nitrophenyl)-5- phenyl(-2H tetrazolium (NBT);
3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H tetrazolium (MTT); 2-phenyl-3-(4-carboxyphenyl)-5-methyl tetrazolium (PCPM); tetrazolium blue (TB); thiocarbamyl nitroblue tetrazolium (TCNBT); tetranitroblue tetrazolium (TNBT); tetrazolium violet (T~; 2-benzothiazothiazolyl-3-(4-carboxy-2-methoxyphenyl)-5-[4-(2-sulfoethylcarbamoyl)phenyl]-20 2H-tetrazolium (WST-4); 2,2'-dibenzothiazolyl-S,5'-bis[4-di(2-sulfoethyl)carbamoylphenyl]-3,3'-(3,3'-dimethoxy- 4,4'-biphenylene)ditetrazolium, disodium salt (WST-S); 2-(p-nitrophenyl)-3-(p-iodophenyl)-5-phenyltetrazolium chloride (INT); and the like. WST-5 is preferred in many embodiments because it readily dissolves in an aqueous medium, which is most compatible with biological samples.
Furthermore, the 25 resulting formazan compound exhibits strong spectral absorption at the purple-blue region, thus reducing the need for correcting the background signal from hemoglobin.
Other useful tetrazolium salts are disclosed in U.S. Pat. Nos. 4,490,465; 4,491,631;
4,598,042; 4,351,899;
4,271,265; 4,247,633; 4,223,090; 4,215,917; 4,142,938; 4,024,021; 3,867,259;
3,867,257;
3,791,931; and 4,254,222; the disclosures of which are herein incorporated by reference.
3o The above described signal producing systems are capable of detecting the presence of a reduced enzyme cofactor in a sample, particularly an aqueous sample and more particularly a physiological sample, e.g. whole blood or a fraction or derivative thereof. A
variety of different reduced enzyme cofactors may be detected using the subject signal producing systems, where representative reduced enzyme cofactors include the reduced forms of the following cofactors: beta-nicotinamide adenine dinucleotide (beta-NAD), beta-nicotinamide adenine dinucleotide phosphate (beta-NADP), thionicotinamide adenine dinucleotide, thionicotinamide adenine dinucleotide phosphate, nicotinamide 1,N6-ethenoadenine dinucleotide, nicotinamide 1,N6-ethenoadenine dinucleotide phosphate, and pyrrolo-quinoline quinone (PQQ). The subject signal producing systems are particularly suited for use in the detection of NADH or NAD(P)H.
In many applications in which the subject signal producing systems find use, the reduced enzyme cofactor is one that is produced following the oxidation of an analyte of to interest in a sample. In many embodiments, therefore, the subject signal producing systems also include the enzyme cofactor and an analyte oxidizing enzyme that is capable of oxidizing the analyte of interest and concomitantly reducing the enzyme cofactor. Enzyme cofactors of interest include those described above, i.e. beta-nicotinamide adenine dinucleotide (beta-NAD), beta-nicotinamide adenine dinucleotide phosphate (beta-NADP), thionicotinamide adenine dinucleotide, thionicotinamide adenine dinucleotide phosphate, nicotinamide I,N6-ethenoadenine dinucleotide, nicotinamide 1,N6-ethenoadenine dinucleotide phosphate, and pyrrolo-quinoline quinone (PQQ). Enzyme cofactors of particular interest that may be included in the subject signal producing systems include:
NADH or NAD(P)H.
2o The analyte oxidizing enzyme present in the signal producing system necessarily depends on the nature of the analyte to be detected with the system.
Representative analyte oxidizing enzymes of interest include: alcohol dehydrogenase for alcohol, formaldehyde dehydrogenase for formaldehyde, glucose dehydrogenase for glucose, glucose-6-phosphate dehydrogenase for glucose-6-phosphate, glutamate dehydrogenase for glutamic acid, glycerol dehydrogenase for glycerol, beta-hydroxybutyrate dehydrogenase for beta-hydroxybutyrate, hydroxysteroid dehydrogenase for steroid, L-lactate dehydrogenase for L-lactate, leucine dehydrogenase for leucine, malate dehydrogenase for malic acid, and pyruvate dehydrogenase for pyruvic acid. As can be seen from the above representative list, the analyte oxidizing enzyme is typically a dehydrogenase.
REAGENT COMPOSITIONS
Also provided by the subject invention are reagent compositions for use in detecting at least a reduced enzyme cofactor, and in many embodiments and analyte, in a sample. The reagent compositions may be fluid, e.g. aqueous, or dry compositions, where in many embodiments the reagent compositions are dry compositions. At a minimum, the subject reagent compositions are ones that include the first and second electron transfer agent and the redox indicator, where these components are described above. Such reagent compositions are suitable for use in the detection of reduced enzyme cofactors, e.g.
NAD(P)H, in a sample. In many embodiments, however, the reagent compositions further include an enzyme cofactor and an analyte oxidizing enzyme, where these components are described above.
REAGENT TEST STRIPS
Also provided by the subject invention are reagent test strips for use in detecting the presence of an analyte in a sample. In particular, the invention provides dry strips for assaying for a particular analyte in whole blood, e.g. in beta-hydroxybutyrate, glucose, etc.
In the broadest sense, the reagent test strip includes a solid support and a dry reagent composition present thereon, where the dry reagent composition is made up of all of the reagent compounds necessary to produce a detectable signal in the presence of the analyte of interest. In most embodiments of the subject invention, the dry reagent composition present on the subject test strip is one that includes the following members: an analyte oxidizing enzyme, an enzyme cofactor, first and second electron transfer agents and a redox indicator, 2o where each of these constituent members are described in greater detail supra.
In many embodiments, the subject test strips include a membrane test pad that is affixed to a solid support. The support may be a plastic - e.g., polystyrene, nylon, or polyester - or metallic sheet or any other suitable material known in the art.
In many embodiments, the test pad preferably comprises a bibulous, such as filter paper or polymer membrane. Associated with the test pad, e.g. coated onto the test pad, incorporated into the test pad, etc., is the reagent composition. The strip may also be configured in more complex arrangements, e.g. where the test pad is present between the support and a surface layer, where one or more reagents employed in sample processing may be present on the surface layer. In addition, flow paths or channels may be present on the test strip, as is known in the 3o art. Of interest in many embodiments are the test strip configurations disclosed in U.S.
Patent No. 5,902,731, the disclosure of which is herein incorporated by reference.
The subject test strips may be fabricated employing any convenient protocol.
One convenient protocol is to contact at least the test pad portion of the strip with an aqueous composition that includes all of the members of the reagent composition that is to be associated with the test pad in the final reagent test strip. Conveniently, the test pad may be immersed in the aqueous composition, maintained therein for a sufficient period of time and then dried, whereby the test pad of the reagent test strip which has associated therewith the s reagent composition is produced. As stated above, the aqueous composition will include the various members of the reagent composition to be associated with the test pad of the reagent test strip, where the various members are present in amounts sufficient to provide for the desired amounts in the reagent composition that is produced on the test pad.
As such, the concentration of non-proteinaceous electron transfer agent present in this aqueous l0 composition typically ranges from about 1 gM to 1000 p,M, usually from about 10 ~tM to 500 ~M; while the concentration of proteinaceous electron transfer agent in the aqueous composition ranges from about 50U to 3000 U, usually from about 100 U to 1000 U. The concentration of redox reagent present in the aqueous composition ranges from about 3 mM
to 36 mM, usually from about 6 mM to 24mM. When present, the enzyme cofactor ranges in 15 concentration from about 1.5 mM to 28 mM, usually from about 3.5mM to 14 mM.
Similarly, the analyte oxidizing agent enzyme ranges in concentration from about 100 U to 2000 U, and usually from about 200 U to 1000 U when present. Other components that may be present in this aqueous composition employed to prepare the reagent test strip include sodium chloride, magnesium chloride, Tris, PSSA, Tetronic 1307, Crotein-SPA, sucrose, 20 oxamic acid, sodium salt, and the like. See the experimental section, infra, for a more detailed description of a representative method for preparing the subject reagent test strips.
METHODS OF ANALYTE DETECTION
The above described signal producing systems, reagent compositions and test strips 25 find use in methods of detecting the presence of, and often the amount of, an analyte in a sample. A variety of different analytes may be detected using the subject methods, where representative analytes include those described above, e.g. alcohol, formaldehyde, glucose, glutamic acid, glycerol, beta-hydroxybutyrate, L-lactate, leucine, malic acid, pyruvic acid, steroids, etc. While in principle, the subject methods may be used to determine the presence, 3o and often concentration, of an analyte in a variety of different physiological samples, such as urine, tears, saliva, and the like, they are particularly suited for use in determining the concentration of an analyte in blood or blood fractions, e.g. blood derived samples, and more particularly in whole blood.
s An important feature of the subject methods is that use of the subject signal producing systems that include both first and second electron transfer agents provides for an accelerated reaction time as compared to a control system, e.g. a system that includes a single electron transfer agent. Generally, the reaction rate is accelerated or enhanced by a factor of 1 to 3 depending on the ratio of PMS and diaphorase. Furthermore, the reaction rate is greater than the theoretical or predicted rate which would be expected based on the summation of the rates provided by the individual electron transfer agents by a factor of 1 to3. Where the reaction rate is measured in terms of K/S per sec (see the experimental section infra) the K/S per sec for a reaction in which the subject signal producing systems to are employed typically ranges from about 0.01 to 10, usually from about 0.05 to 5 and more usually from about 0.1 to 2.
In the subject methods, the sample and the signal producing system are combined into a reaction mixture, the reaction is allowed to proceed for a sufficient period to time to generate a signal indicative of the presence of (and often amount of) analyte in the sample, 15 and the resultant signal is detected and related to the presence of (and often amount of) analyte in the sample. In the broadest sense, the reaction mixture may be produced in any convenient environment, such as a cuvette or other fluid containment means.
However, in many embodiments, the above steps take place on a reagent test strip as described supra. As such, the subject methods are now discussed further in terms of methods in which a reagent 2o test strip is employed.
In practicing the subject methods, the first step is to apply a quantity of the physiological sample to the test strip, where the test strip is described supra. The amount of physiological sample, e.g. blood, that is applied to the test strip may vary, but generally ranges from about 2~L to 40~.L, usually from about Sp.L to 20gL. Because of the nature 25 ofthe subject test strip, the blood sample size that is applied to the test strip may be relatively small, ranging in size from about 2p.L to 40~t.L,, usually from about Sp.L, to 20p.L,.
Where blood is the physiological sample, blood samples of a variety of different hematocrits may be assayed with the subject methods, where the hematocrit may range from about 20%
to 65%, usually from about 25% to 60%.
3o Following application of the sample to the test strip, the sample is allowed to react with the members of the signal producing system to produce a detectable product that is present in an amount proportional to the initial amount of the analyte of interest present in the sample. The amount of detectable product, i.e. signal produced by the signal producing system, is then determined and related to the amount of analyte in the initial sample. In certain embodiments, automated instruments that perform the above mentioned detection and relation steps are employed. The above described reaction, detection and relating steps, as well as instruments for performing the same, are further described in U. S.
Patent Nos.
4,734,360; 4,900,666; 4,935,346; 5,059,394; 5,304,468; 5,306,623; 5,418,142;
5,426,032;
5,515,170; 5,526,120; 5,563,042; 5,620,863; 5,753,429; 5,573,452; 5,780,304;
5,789,255;
5,843,691; 5,846,486; 5,902,731; 5,968,836 and 5,972,294; the disclosures of which are herein incorporated by reference. In the relation step, the derived analyte concentration takes into account the constant contribution of competing reactions to the observed signal, 1o e.g. by calibrating the instrument accordingly.
KITS
Also provided by the subject invention are kits for use in practicing the subject methods. The kits of the subject invention at least include a signal producing system as described above, where the signal producing system components may be combined into a single reagent composition or separated, e.g. present in separate containers.
In certain embodiments, the signal producing system will be present in the kits in the form of a reagent test strip, as described supra. The subject kits may further include a means for obtaining a physiological sample. For example, where the physiological sample is blood, the subject kits 2o may further include a means for obtaining a blood sample, such as a lance for sticking a finger, a lance actuation means, and the like. In addition, the subject kits may include a control solution or standard, e.g. an analyte control solution that contains a standardized concentration of analyte. In certain embodiments, the kits also include an automated instrument, as described above, for detecting the amount of product produced on the strip following sample application and relating the detected product to the amount of analyte in the sample. Finally, the kits include instructions for using the subject kit components in the determination of an analyte concentration in a physiological sample. These instructions may be present on one or more of the packaging, a label insert, containers present in the kits, and the like.
The following examples are offered by way of illustration and not by way of limitation.
EXPERIMENTAL
A. Preparation of Ketone Test Strip An 0.8 ~tm nylon membrane obtained from Cuno (Meridien, CT) was dipped into the reagent of Table 1, until saturated.
Table 1 Com onent _ Quantity Water 100 ml Tris(hydroxvmeth 1)aminomethane 1.2 sodium chloride (MW 56.44, Si ma St. Louis, 560 m MO) Ma esium Chloride (MW 203, Si , St. Louis, MO) 2.5 PSSA, of s enesulfonic acid, sodium salt (MW 3 70,000) Crotein-SPA (Croda Inc., Parsi an , N.n 3 Oxamic acid, sodium salt 250 m Tetronic 1307 (BASF Co oration, Mount Olive, 2 m N.n Sucrose (MW 342.30, Aldrich Chemicals, Milwaukee5 gm WI) NAD (MW 663.4, N7004, Si a, St. Louis, MO) 450 m D-3-hvdroxvbutvrate dehvdrogenase 50.000 U
WST-5 (MW 1331.37, Dojindo, 1a an) 1.8 Dia horase 0-15000 U
Phenazine Methosulfate (PMS) 0-3 m The excess reagent was scraped off gently with a glass rod. The resulting membrane was hung to dry in a 56 °C oven for 10 minutes. Porex (0.6 mm thick) was soaked in the 5%
nitrite solution and then hung to dry in a 100 °C oven for ten hours.
Finally, the membrane 1o was laminated between a polyester stock (0.4 mm Melenex~ polyester from ICI
America, Wilmington DE) and the nitrite impregnated Porex.
B. Assays Using the following protocol, 10 pL of aqueous samples comprising 40mg/dL (D) (3-hydroxybutyrate were tested on strips as described above, where the strips varied in terms of the amount of PMS and/or Diaphorase present on the strip. A 10 ml aqueous sample was applied onto a freshly prepared test strip. The strip was inserted into a reflectometer and data acquisition was commenced. The relectance of the reading strip was monitored at 660 nm at one-second intervals for two minutes. Next, the data were uploaded from the 2o reflectometer's memory buffer to a personal computer via a modified serial cable. The reaction rate was calculated based on the initial rate of change in K/S at the range where the reaction profile was linear. The results summarized in Table 2 were averages of five replicates.. In each individual assay, the reaction rate (in terms of K/S per sec) was observed.
(K/S is a measure of reflectance, discussed and defined in USP 4,935,346, col.
14, the disclosure of which is herein incorporated by reference.) Table 2 provides the results.
Table 2 DAD DAD and and PMS
PMS Formulated Formulation To ether Separately DAD Rate PMS Rate SeparatetDAD PMS Together U/ml (K/S/sec)( m) (K/S/sec)(K/S/sec)U/ml ( m) (K/S/sec) 150 0.0166 10 0.013 0.0296 150 10 0.0385 300 0.0392 20 0.0225 0.0617 300 20 0.1054 600 0.0943 40 0.0484 0.1427 600 40 0.3095 900 0.1666 60 0.078 0.2446 900 60 0.5861 1200 0.1787 80 0.1085 0.2872 1200 80 0.9107 1500 0.2866 100 0.13 0.4166 1500 100 Too fast*
f Theoretical rate, i.e. the predicted rate based on the sum ot-the reaction rate catalyzed by s diaphorase and PMS individually.
* The reaction is too fast and difficult to calculate the rate precisely.
C. Observed Rate v. Theoretical Rate Table 3 below provides a comparison of the observed rate and the expected or to theoretical rate for the above described assays.
Table 3 Theoretical Rate (K/S er Observed Rate (K/5 er sec) sec) 0.0296 0.0385 0.0617 0.1054 0.1427 0.3095 0.2446 0.5861 0.2872 0.9107 Fig. 1 provides a graph of the observed rate vs. the theoretical rate.
As can be seen by the graph of Figure 1, the reaction rate of the signal producing 15 system of the test strip is accelerated by the presence of both PMS and Diaphorase, where the magnitude of the observed acceleration is unexpectedly greater than the predicted amount of acceleration based on the sum of the reaction rates of systems having PMS or Diaphorase individually.
2o It is evident from the above results and discussion that the subject invention provides for a significant and unexpected enhancement in the rate of reaction observed in an analyte detection protocol based on the oxidation of an analyte and the concomitant reduction of a redox indicator. In addition, the subject invention provides for a more economical manner of analyte detection, as compared to certain prior art methods, e.g. ones that rely solely on diaphorase as the electron transfer agent. As such, the subject invention represents a significant contribution to the art.
All publications and patents cited in this specification are herein incorporated by reference as if each individual publication or patent were specifically and individually indicated to be incorporated by reference. The citation of any publication is for its disclosure prior to the filing date and should not be construed as an admission that the present invention is not entitled to antedate such publication by virtue of prior invention.
to Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it is readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims.
COFACTOR IN A SAMPLE AND METHODS FOR USING THE SAME
INTRODUCTION
Field of the Invention The field of this invention is analyte detection, particularly reagent systems for use in analyte detection.
Back round of the Invention 1o Analyte detection in physiological fluids, e.g. blood or blood derived products, is of ever increasing importance to today's society. Analyte detection assays find use in a variety of applications, including clinical laboratory testing, home testing, etc., where the results of such testing play a prominent role in diagnosis and management in a variety of disease conditions. Analytes of interest include alcohol, formaldehyde, glucose, glutamic acid, 15 glycerol, beta-hydroxybutyrate, L-lactate, leucine, malic acid, pyruvic acid, steroids, etc. In response to this growing importance of analyte detection, a variety of analyte detection protocols and devices for both clinical and home use have been developed. Many of the protocols and devices that have been developed to date employ a signal producing system to identify the presence of the analyte of interest in a physiological sample, such as blood.
2o One type of signal producing system that finds use in the detection of a variety of different analytes is one in which a dehydrogenase oxidizes the analyte of interest and concomitantly reduces an enzyme cofactor, such as NAD(P)+. The reduced form of the cofactor, e.g. NAD(P)H, is then detected through subsequent reaction with a cofactor oxidizing agent, e.g. phenazine methosulfate or a diaphorase, that transfers an electron to a 25 redox indicator, such as a tetrazolium salt, to produce a detectable product.
While a variety of such signal producing systems have been developed to date for use in the detection of a wide variety of different analytes, there continues to be a need for the fi~rther development of such systems. For example, a signal producing system which provided for an enhanced reaction rate and a lower cost would be of great interest.
3o Relevant Literature U.S. Patents of interest include: 4,629,697; 5,126,247 and 5,902,731. See also Raap et al., Histochem. J. (1983) 15:881-893.
SUMMARY OF THE INVENTION
Signal producing systems, reagent compositions, test strips and kits of the same, as well as methods for their use in the detection of an analyte in a sample, are provided. The subject signal producing systems are characterized by having at least a first and second electron transfer agent and a redox indicator, where in many preferred embodiments the systems include a proteinaceous and non-proteinaceous electron transfer agent, e.g. a phenazine compound and a diaphorase. In many preferred embodiments, the subject systems and kits further include both an enzyme cofactor and an enzyme having an analyte oxidizing activity, e.g. an analyte dehydrogenase. The subject systems, reagent compositions, test 1o strips and kits find use in the detection of a wide variety of analytes in a sample, such as a physiological sample, e.g. blood or a fraction thereof.
BRIEF DESCRIPTION OF THE FIGURES
Fig. 1 provides a graphical representation of the observed rate of reaction in a test strip according to the subject invention vs. the theoretical expected rate of reaction for a test strip that includes both PMS and a diaphorase, clearly demonstrating that the use of both a non-proteinaceous and proteinaceous electron transfer agent, e.g. PMS and a diaphorase, provides for an unexpected increase in the rate of reaction.
2o DESCRIPTION OF THE SPECIFIC EMBODIMENTS
Signal producing systems, reagent compositions, test strips and kits of the same, as well as methods for their use in the detection of an analyte in a sample, are provided. The subject signal producing systems are characterized by having at least a first and second electron transfer agent and a redox indicator, where in many preferred embodiments the systems include a proteinaceous and non-proteinaceous electron transfer agent, e.g. a phenazine compound and a diaphorase. In many preferred embodiments, the subject systems and kits further include both an enzyme cofactor and an enzyme having an analyte oxidizing activity, e.g. an analyte dehydrogenase. The subject systems, reagent compositions, test strips and kits find use in the detection of a wide variety of analytes in a sample, such as a 3o physiological sample, e.g. blood or a fraction thereof.
Before the subject invention is described further, it is to be understood that the invention is not limited to the particular embodiments of the invention described below, as variations of the particular embodiments may be made and still fall within the scope of the appended claims. It is also to be understood that the terminology employed is for the purpose of describing particular embodiments, and is not intended to be limiting.
Instead, the scope of the present invention will be established by the appended claims.
In this specification and the appended claims, singular references include the plural, unless the context clearly dictates otherwise. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood to one of ordinary skill in the art to which this invention belongs.
/o SIGNAL PRODUCING SYSTEMS
As summarized above, the subject invention provides a signal producing system that is capable of detecting the presence of a reduced enzyme cofactor in a sample.
By signal producing system is meant a collection of two or more compounds or molecules which are 15 capable of acting in concert, when combined, to produce a detectable signal that is indicative of the presence of, and often amount of, a particular analyte in a given sample. The term signal producing system is used broadly to encompass both a mixture of all of the reagent constituents of the signal producing system as well as a system in which one or more of the reagent constituents are separated from the remainder of the reagent constituents, e.g. as is 2o present in a kit.
A feature of the subject signal producing systems is the presence of two distinct electron transfer agents. By electron transfer agent is meant a compound or molecule that can transfer an electron, in the form of a hydride ion, from a reduced enzyme cofactor to a redox indicator. In the subject signal producing systems, the first of the distinct electron 25 transfer agents is a low molecular weight molecule, while the second electron transfer agent is a high molecular weight molecule. In this specification, low molecular weight means a molecular weight that does not exceed about 2000 daltons, usually about 1000 daltons and in many embodiments about 500 daltons. High molecular weight means a molecular weight of at least about 5000 daltons and in many embodiments 10,000 or 20,000 daltons or higher.
3o The molecular weight of the high molecular weight electron transfer agent often will not exceed about 100,000 daltons. In many embodiments, the low molecular weight electron transfer agent is a non-proteinaceous compound while the high molecular weight electron transfer agent is a proteinaceous compound. By proteinaceous is meant a polypeptide or polymeric mimetic thereof.
A variety of low molecular weight non-proteinaceous electron transfer agents are of interest. These agents include: flavins such as riboflavin (RBF), alloxazine s (ALL) and lumichrome (LC); phenazines such as phenazine, phenazine methosulfate (PMS), phenazine ethosulfate, methoxyphenazine methosulfate and safranine; methyl-1, 4-naphthol (menadione), phenothiazines such as PT and its radical cation, PT+, thionin (TH), azure A
(AA), azure B (AB), azure C (AC), methylene blue (MB), methylene green (MG) and toluidine blue O (TOL); phenoxazines such as phenoxazine (POA), basic blue 3 (BB3), and to brilliant cresyl blue ALD (BCBA), benzo-oc-phenazoxonium chloride (Medola's blue);
Indophenols such as 2,6-dichlorophenol indophenol (DCIP); and Indamines such as Bindschedler's green and phenylene blue; and the like.: Of particular interest in many embodiments are phenazine compounds, e.g. PMS, phenazine ethosulfate, methoxyphenazine methosulfate and safranine, where PMS is the low molecular weight, is non-proteinaceous electron transfer agent in many embodiments.
In many embodiments, the high molecular weight proteinaceous electron transfer agent is an enzyme that is capable of oxidizing a reduced cofactor, e.g.
NAD(P)H, and concomitantly reducing a redox indicator. In many embodiments, this electron transfer enzyme is a diaphorase, such as lipoic dehydrogenase, ferredoxin-NADP
reductase, 20 lipoamide dehydrogenase, NADPH dehydrogenase, etc. A variety of diaphoreses are available and may be employed, where representative commercially available diaphoreses that may be present in the subject signal producing systems include bacillus diaphorase, clostridium diaphorase, vibrio diaphorase, porcine diaphorase, and the like.
In the subject signal producing systems, the ratio of the first to the second electron 25 transfer agent is chosen to provide for an accelerated reaction rate as compared to a control, e.g. a comparable signal producing system with a single electron transfer agent, e.g. only PMS or a diaphorase. Typically, the ratio of the first to the second electron transfer agent in the subject systems ranges from about 0.001 to 10, usually from about 0.01 to 1.0 and more usually from about 0.05 to 0.5 (nmole/U), respectively.
3o In addition to the above described first and second electron transfer agents, the subject signal producing systems also include a redox indicator. By redox indicator is meant a compound that is capable of being reduced by the electron transfer agents to produce a detectable, e.g. chromogenic, product. Where the redox indicator produces a chromogenic product, i.e. the redox indicator is a chromogen, suitable chromogens are any compound capable of changing color upon reduction by one or more electrons, where suitable chromogens are generally ones that accept electrons from the electron transfer agents, described above.
A variety of different redox indicator compounds are of interest. Compounds of interest include: oxazines, thiazines, and tetrazolium salts. Of particular interest in many embodiments are tetrazolium salts which are capable of accepting the captured hydride from the electron transfer agents to form a colored formazan product. In many embodiments, these salts have the advantageous feature of being faint yellow in the oxidized form, but turn to bright visible colors upon electron reduction and conversion to formazan dyes. Tetrazolium compounds or salts that are of particular interest include: 2-(2' benzothiazolyl)-5-styryl-3-(4'-phthalhydrazidyl) tetrazolium (BSPT); 2-benzothiazolyl-(2)-3,5-diphenyl tetrazolium (BTDP); 2,3-di(4-nitrophenyl) tetrazolium (DNP); 2,5-diphenyl-3-(4-styrylphenyl) tetrazolium (DPSP); distyryl nitroblue tetrazolium (DS-NBT); 3,3'-[3,3'-dimethoxy-(1,1'-15 biphenyl)-4,4'-diyl]-bis[2-(4-nitrophenyl)-5- phenyl(-2H tetrazolium (NBT);
3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H tetrazolium (MTT); 2-phenyl-3-(4-carboxyphenyl)-5-methyl tetrazolium (PCPM); tetrazolium blue (TB); thiocarbamyl nitroblue tetrazolium (TCNBT); tetranitroblue tetrazolium (TNBT); tetrazolium violet (T~; 2-benzothiazothiazolyl-3-(4-carboxy-2-methoxyphenyl)-5-[4-(2-sulfoethylcarbamoyl)phenyl]-20 2H-tetrazolium (WST-4); 2,2'-dibenzothiazolyl-S,5'-bis[4-di(2-sulfoethyl)carbamoylphenyl]-3,3'-(3,3'-dimethoxy- 4,4'-biphenylene)ditetrazolium, disodium salt (WST-S); 2-(p-nitrophenyl)-3-(p-iodophenyl)-5-phenyltetrazolium chloride (INT); and the like. WST-5 is preferred in many embodiments because it readily dissolves in an aqueous medium, which is most compatible with biological samples.
Furthermore, the 25 resulting formazan compound exhibits strong spectral absorption at the purple-blue region, thus reducing the need for correcting the background signal from hemoglobin.
Other useful tetrazolium salts are disclosed in U.S. Pat. Nos. 4,490,465; 4,491,631;
4,598,042; 4,351,899;
4,271,265; 4,247,633; 4,223,090; 4,215,917; 4,142,938; 4,024,021; 3,867,259;
3,867,257;
3,791,931; and 4,254,222; the disclosures of which are herein incorporated by reference.
3o The above described signal producing systems are capable of detecting the presence of a reduced enzyme cofactor in a sample, particularly an aqueous sample and more particularly a physiological sample, e.g. whole blood or a fraction or derivative thereof. A
variety of different reduced enzyme cofactors may be detected using the subject signal producing systems, where representative reduced enzyme cofactors include the reduced forms of the following cofactors: beta-nicotinamide adenine dinucleotide (beta-NAD), beta-nicotinamide adenine dinucleotide phosphate (beta-NADP), thionicotinamide adenine dinucleotide, thionicotinamide adenine dinucleotide phosphate, nicotinamide 1,N6-ethenoadenine dinucleotide, nicotinamide 1,N6-ethenoadenine dinucleotide phosphate, and pyrrolo-quinoline quinone (PQQ). The subject signal producing systems are particularly suited for use in the detection of NADH or NAD(P)H.
In many applications in which the subject signal producing systems find use, the reduced enzyme cofactor is one that is produced following the oxidation of an analyte of to interest in a sample. In many embodiments, therefore, the subject signal producing systems also include the enzyme cofactor and an analyte oxidizing enzyme that is capable of oxidizing the analyte of interest and concomitantly reducing the enzyme cofactor. Enzyme cofactors of interest include those described above, i.e. beta-nicotinamide adenine dinucleotide (beta-NAD), beta-nicotinamide adenine dinucleotide phosphate (beta-NADP), thionicotinamide adenine dinucleotide, thionicotinamide adenine dinucleotide phosphate, nicotinamide I,N6-ethenoadenine dinucleotide, nicotinamide 1,N6-ethenoadenine dinucleotide phosphate, and pyrrolo-quinoline quinone (PQQ). Enzyme cofactors of particular interest that may be included in the subject signal producing systems include:
NADH or NAD(P)H.
2o The analyte oxidizing enzyme present in the signal producing system necessarily depends on the nature of the analyte to be detected with the system.
Representative analyte oxidizing enzymes of interest include: alcohol dehydrogenase for alcohol, formaldehyde dehydrogenase for formaldehyde, glucose dehydrogenase for glucose, glucose-6-phosphate dehydrogenase for glucose-6-phosphate, glutamate dehydrogenase for glutamic acid, glycerol dehydrogenase for glycerol, beta-hydroxybutyrate dehydrogenase for beta-hydroxybutyrate, hydroxysteroid dehydrogenase for steroid, L-lactate dehydrogenase for L-lactate, leucine dehydrogenase for leucine, malate dehydrogenase for malic acid, and pyruvate dehydrogenase for pyruvic acid. As can be seen from the above representative list, the analyte oxidizing enzyme is typically a dehydrogenase.
REAGENT COMPOSITIONS
Also provided by the subject invention are reagent compositions for use in detecting at least a reduced enzyme cofactor, and in many embodiments and analyte, in a sample. The reagent compositions may be fluid, e.g. aqueous, or dry compositions, where in many embodiments the reagent compositions are dry compositions. At a minimum, the subject reagent compositions are ones that include the first and second electron transfer agent and the redox indicator, where these components are described above. Such reagent compositions are suitable for use in the detection of reduced enzyme cofactors, e.g.
NAD(P)H, in a sample. In many embodiments, however, the reagent compositions further include an enzyme cofactor and an analyte oxidizing enzyme, where these components are described above.
REAGENT TEST STRIPS
Also provided by the subject invention are reagent test strips for use in detecting the presence of an analyte in a sample. In particular, the invention provides dry strips for assaying for a particular analyte in whole blood, e.g. in beta-hydroxybutyrate, glucose, etc.
In the broadest sense, the reagent test strip includes a solid support and a dry reagent composition present thereon, where the dry reagent composition is made up of all of the reagent compounds necessary to produce a detectable signal in the presence of the analyte of interest. In most embodiments of the subject invention, the dry reagent composition present on the subject test strip is one that includes the following members: an analyte oxidizing enzyme, an enzyme cofactor, first and second electron transfer agents and a redox indicator, 2o where each of these constituent members are described in greater detail supra.
In many embodiments, the subject test strips include a membrane test pad that is affixed to a solid support. The support may be a plastic - e.g., polystyrene, nylon, or polyester - or metallic sheet or any other suitable material known in the art.
In many embodiments, the test pad preferably comprises a bibulous, such as filter paper or polymer membrane. Associated with the test pad, e.g. coated onto the test pad, incorporated into the test pad, etc., is the reagent composition. The strip may also be configured in more complex arrangements, e.g. where the test pad is present between the support and a surface layer, where one or more reagents employed in sample processing may be present on the surface layer. In addition, flow paths or channels may be present on the test strip, as is known in the 3o art. Of interest in many embodiments are the test strip configurations disclosed in U.S.
Patent No. 5,902,731, the disclosure of which is herein incorporated by reference.
The subject test strips may be fabricated employing any convenient protocol.
One convenient protocol is to contact at least the test pad portion of the strip with an aqueous composition that includes all of the members of the reagent composition that is to be associated with the test pad in the final reagent test strip. Conveniently, the test pad may be immersed in the aqueous composition, maintained therein for a sufficient period of time and then dried, whereby the test pad of the reagent test strip which has associated therewith the s reagent composition is produced. As stated above, the aqueous composition will include the various members of the reagent composition to be associated with the test pad of the reagent test strip, where the various members are present in amounts sufficient to provide for the desired amounts in the reagent composition that is produced on the test pad.
As such, the concentration of non-proteinaceous electron transfer agent present in this aqueous l0 composition typically ranges from about 1 gM to 1000 p,M, usually from about 10 ~tM to 500 ~M; while the concentration of proteinaceous electron transfer agent in the aqueous composition ranges from about 50U to 3000 U, usually from about 100 U to 1000 U. The concentration of redox reagent present in the aqueous composition ranges from about 3 mM
to 36 mM, usually from about 6 mM to 24mM. When present, the enzyme cofactor ranges in 15 concentration from about 1.5 mM to 28 mM, usually from about 3.5mM to 14 mM.
Similarly, the analyte oxidizing agent enzyme ranges in concentration from about 100 U to 2000 U, and usually from about 200 U to 1000 U when present. Other components that may be present in this aqueous composition employed to prepare the reagent test strip include sodium chloride, magnesium chloride, Tris, PSSA, Tetronic 1307, Crotein-SPA, sucrose, 20 oxamic acid, sodium salt, and the like. See the experimental section, infra, for a more detailed description of a representative method for preparing the subject reagent test strips.
METHODS OF ANALYTE DETECTION
The above described signal producing systems, reagent compositions and test strips 25 find use in methods of detecting the presence of, and often the amount of, an analyte in a sample. A variety of different analytes may be detected using the subject methods, where representative analytes include those described above, e.g. alcohol, formaldehyde, glucose, glutamic acid, glycerol, beta-hydroxybutyrate, L-lactate, leucine, malic acid, pyruvic acid, steroids, etc. While in principle, the subject methods may be used to determine the presence, 3o and often concentration, of an analyte in a variety of different physiological samples, such as urine, tears, saliva, and the like, they are particularly suited for use in determining the concentration of an analyte in blood or blood fractions, e.g. blood derived samples, and more particularly in whole blood.
s An important feature of the subject methods is that use of the subject signal producing systems that include both first and second electron transfer agents provides for an accelerated reaction time as compared to a control system, e.g. a system that includes a single electron transfer agent. Generally, the reaction rate is accelerated or enhanced by a factor of 1 to 3 depending on the ratio of PMS and diaphorase. Furthermore, the reaction rate is greater than the theoretical or predicted rate which would be expected based on the summation of the rates provided by the individual electron transfer agents by a factor of 1 to3. Where the reaction rate is measured in terms of K/S per sec (see the experimental section infra) the K/S per sec for a reaction in which the subject signal producing systems to are employed typically ranges from about 0.01 to 10, usually from about 0.05 to 5 and more usually from about 0.1 to 2.
In the subject methods, the sample and the signal producing system are combined into a reaction mixture, the reaction is allowed to proceed for a sufficient period to time to generate a signal indicative of the presence of (and often amount of) analyte in the sample, 15 and the resultant signal is detected and related to the presence of (and often amount of) analyte in the sample. In the broadest sense, the reaction mixture may be produced in any convenient environment, such as a cuvette or other fluid containment means.
However, in many embodiments, the above steps take place on a reagent test strip as described supra. As such, the subject methods are now discussed further in terms of methods in which a reagent 2o test strip is employed.
In practicing the subject methods, the first step is to apply a quantity of the physiological sample to the test strip, where the test strip is described supra. The amount of physiological sample, e.g. blood, that is applied to the test strip may vary, but generally ranges from about 2~L to 40~.L, usually from about Sp.L to 20gL. Because of the nature 25 ofthe subject test strip, the blood sample size that is applied to the test strip may be relatively small, ranging in size from about 2p.L to 40~t.L,, usually from about Sp.L, to 20p.L,.
Where blood is the physiological sample, blood samples of a variety of different hematocrits may be assayed with the subject methods, where the hematocrit may range from about 20%
to 65%, usually from about 25% to 60%.
3o Following application of the sample to the test strip, the sample is allowed to react with the members of the signal producing system to produce a detectable product that is present in an amount proportional to the initial amount of the analyte of interest present in the sample. The amount of detectable product, i.e. signal produced by the signal producing system, is then determined and related to the amount of analyte in the initial sample. In certain embodiments, automated instruments that perform the above mentioned detection and relation steps are employed. The above described reaction, detection and relating steps, as well as instruments for performing the same, are further described in U. S.
Patent Nos.
4,734,360; 4,900,666; 4,935,346; 5,059,394; 5,304,468; 5,306,623; 5,418,142;
5,426,032;
5,515,170; 5,526,120; 5,563,042; 5,620,863; 5,753,429; 5,573,452; 5,780,304;
5,789,255;
5,843,691; 5,846,486; 5,902,731; 5,968,836 and 5,972,294; the disclosures of which are herein incorporated by reference. In the relation step, the derived analyte concentration takes into account the constant contribution of competing reactions to the observed signal, 1o e.g. by calibrating the instrument accordingly.
KITS
Also provided by the subject invention are kits for use in practicing the subject methods. The kits of the subject invention at least include a signal producing system as described above, where the signal producing system components may be combined into a single reagent composition or separated, e.g. present in separate containers.
In certain embodiments, the signal producing system will be present in the kits in the form of a reagent test strip, as described supra. The subject kits may further include a means for obtaining a physiological sample. For example, where the physiological sample is blood, the subject kits 2o may further include a means for obtaining a blood sample, such as a lance for sticking a finger, a lance actuation means, and the like. In addition, the subject kits may include a control solution or standard, e.g. an analyte control solution that contains a standardized concentration of analyte. In certain embodiments, the kits also include an automated instrument, as described above, for detecting the amount of product produced on the strip following sample application and relating the detected product to the amount of analyte in the sample. Finally, the kits include instructions for using the subject kit components in the determination of an analyte concentration in a physiological sample. These instructions may be present on one or more of the packaging, a label insert, containers present in the kits, and the like.
The following examples are offered by way of illustration and not by way of limitation.
EXPERIMENTAL
A. Preparation of Ketone Test Strip An 0.8 ~tm nylon membrane obtained from Cuno (Meridien, CT) was dipped into the reagent of Table 1, until saturated.
Table 1 Com onent _ Quantity Water 100 ml Tris(hydroxvmeth 1)aminomethane 1.2 sodium chloride (MW 56.44, Si ma St. Louis, 560 m MO) Ma esium Chloride (MW 203, Si , St. Louis, MO) 2.5 PSSA, of s enesulfonic acid, sodium salt (MW 3 70,000) Crotein-SPA (Croda Inc., Parsi an , N.n 3 Oxamic acid, sodium salt 250 m Tetronic 1307 (BASF Co oration, Mount Olive, 2 m N.n Sucrose (MW 342.30, Aldrich Chemicals, Milwaukee5 gm WI) NAD (MW 663.4, N7004, Si a, St. Louis, MO) 450 m D-3-hvdroxvbutvrate dehvdrogenase 50.000 U
WST-5 (MW 1331.37, Dojindo, 1a an) 1.8 Dia horase 0-15000 U
Phenazine Methosulfate (PMS) 0-3 m The excess reagent was scraped off gently with a glass rod. The resulting membrane was hung to dry in a 56 °C oven for 10 minutes. Porex (0.6 mm thick) was soaked in the 5%
nitrite solution and then hung to dry in a 100 °C oven for ten hours.
Finally, the membrane 1o was laminated between a polyester stock (0.4 mm Melenex~ polyester from ICI
America, Wilmington DE) and the nitrite impregnated Porex.
B. Assays Using the following protocol, 10 pL of aqueous samples comprising 40mg/dL (D) (3-hydroxybutyrate were tested on strips as described above, where the strips varied in terms of the amount of PMS and/or Diaphorase present on the strip. A 10 ml aqueous sample was applied onto a freshly prepared test strip. The strip was inserted into a reflectometer and data acquisition was commenced. The relectance of the reading strip was monitored at 660 nm at one-second intervals for two minutes. Next, the data were uploaded from the 2o reflectometer's memory buffer to a personal computer via a modified serial cable. The reaction rate was calculated based on the initial rate of change in K/S at the range where the reaction profile was linear. The results summarized in Table 2 were averages of five replicates.. In each individual assay, the reaction rate (in terms of K/S per sec) was observed.
(K/S is a measure of reflectance, discussed and defined in USP 4,935,346, col.
14, the disclosure of which is herein incorporated by reference.) Table 2 provides the results.
Table 2 DAD DAD and and PMS
PMS Formulated Formulation To ether Separately DAD Rate PMS Rate SeparatetDAD PMS Together U/ml (K/S/sec)( m) (K/S/sec)(K/S/sec)U/ml ( m) (K/S/sec) 150 0.0166 10 0.013 0.0296 150 10 0.0385 300 0.0392 20 0.0225 0.0617 300 20 0.1054 600 0.0943 40 0.0484 0.1427 600 40 0.3095 900 0.1666 60 0.078 0.2446 900 60 0.5861 1200 0.1787 80 0.1085 0.2872 1200 80 0.9107 1500 0.2866 100 0.13 0.4166 1500 100 Too fast*
f Theoretical rate, i.e. the predicted rate based on the sum ot-the reaction rate catalyzed by s diaphorase and PMS individually.
* The reaction is too fast and difficult to calculate the rate precisely.
C. Observed Rate v. Theoretical Rate Table 3 below provides a comparison of the observed rate and the expected or to theoretical rate for the above described assays.
Table 3 Theoretical Rate (K/S er Observed Rate (K/5 er sec) sec) 0.0296 0.0385 0.0617 0.1054 0.1427 0.3095 0.2446 0.5861 0.2872 0.9107 Fig. 1 provides a graph of the observed rate vs. the theoretical rate.
As can be seen by the graph of Figure 1, the reaction rate of the signal producing 15 system of the test strip is accelerated by the presence of both PMS and Diaphorase, where the magnitude of the observed acceleration is unexpectedly greater than the predicted amount of acceleration based on the sum of the reaction rates of systems having PMS or Diaphorase individually.
2o It is evident from the above results and discussion that the subject invention provides for a significant and unexpected enhancement in the rate of reaction observed in an analyte detection protocol based on the oxidation of an analyte and the concomitant reduction of a redox indicator. In addition, the subject invention provides for a more economical manner of analyte detection, as compared to certain prior art methods, e.g. ones that rely solely on diaphorase as the electron transfer agent. As such, the subject invention represents a significant contribution to the art.
All publications and patents cited in this specification are herein incorporated by reference as if each individual publication or patent were specifically and individually indicated to be incorporated by reference. The citation of any publication is for its disclosure prior to the filing date and should not be construed as an admission that the present invention is not entitled to antedate such publication by virtue of prior invention.
to Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it is readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims.
Claims (35)
1. A signal producing system for detecting the presence of a reduced cofactor in a sample, said system comprising:
first and second electron transfer agents capable of oxidizing a reduced cofactor; and a redox indicator.
first and second electron transfer agents capable of oxidizing a reduced cofactor; and a redox indicator.
2. The signal producing system according to Claim 1, wherein said first electron transfer agent is a low molecular weight electron transfer agent.
3. The signal producing system according to Claim 2, wherein said low molecular weight electron transfer agent is a phenazine compound.
4. The signal producing system according to Claim 1, wherein said second electron transfer agent is a high molecular weight electron transfer agent.
5. The signal producing system according to Claim 1, wherein said high molecular weight electron transfer agent is a proteinaceous compound.
6. The signal producing system according to Claim 5, wherein said proteinaceous compound is an enzyme.
7. The signal producing system according to Claim 1, wherein said redox indicator is a tetrazolium compound.
8. The signal producing system according to Claim 1, wherein said signal producing system further comprises an enzyme cofactor.
9. The signal producing system according to Claim 1, wherein said system further comprises an analyte oxidizing enzyme.
10. The signal producing system according to Claim 1, wherein said signal producing system is present as a reagent composition.
11. A reagent composition for use in detecting the presence of an analyte in a sample, said composition comprising:
an analyte oxidizing enzyme;
an enzyme cofactor;
a non-proteinaceous electron transfer agent;
a proteinaceous electron transfer agent; and a redox indicator.
an analyte oxidizing enzyme;
an enzyme cofactor;
a non-proteinaceous electron transfer agent;
a proteinaceous electron transfer agent; and a redox indicator.
12. The reagent composition according to Claim 11, wherein said enzyme cofactor is NAD(P)+.
13. The reagent composition according to Claim 11, wherein said non-proteinaceous electron transfer agent is a phenazine compound.
14. The reagent composition according to Claim 11, wherein said proteinaceous electron transfer agent is a diaphorase.
15. The reagent composition according to Claim 11, wherein said redox indicator is a tetrazolium compound.
16. The reagent composition according to Claim 11, wherein said composition is a dry reagent composition.
17. A reagent composition for use in detecting the presence of an analyte in a sample, said composition comprising:
an analyte dehydrogenase NAD(P)+;
a phenazine compound;
a diaphorase; and a tetrazolium compound.
an analyte dehydrogenase NAD(P)+;
a phenazine compound;
a diaphorase; and a tetrazolium compound.
18. The reagent composition according to Claim 17, wherein said phenazine compound is phenazine methosulfate.
19. The reagent composition according to Claim 17, wherein said composition is a dry reagent composition.
20. The reagent composition according to Claim 19, wherein said dry reagent composition is present on a test strip.
21. A reagent test strip comprising:
(a) a support element; and (b) a dry reagent composition comprising:
(i) an analyte oxidizing enzyme;
(ii) an enzyme cofactor;
(iii) a non-proteinaceous electron transfer agent;
(iv) a proteinaceous electron transfer agent; and (v) a redox indicator.
(a) a support element; and (b) a dry reagent composition comprising:
(i) an analyte oxidizing enzyme;
(ii) an enzyme cofactor;
(iii) a non-proteinaceous electron transfer agent;
(iv) a proteinaceous electron transfer agent; and (v) a redox indicator.
22. The reagent test strip according to Claim 21, wherein said first enzyme is a dehydrogenase.
23. The reagent test strip according to Claim 21, wherein said cofactor is NAD(P)+.
24. The reagent test strip according to Claim 21, wherein said non-proteinaceous electron transfer agent is a phenazine compound.
25. The reagent test strip according to Claim 24, wherein said phenazine compound is phenazine methosulfate.
26. The reagent test strip according to Claim 21, wherein said proteinaceous electron transfer agent is a diaphorase.
27. The reagent test strip according to Claim 21, wherein said redox indicator is a tetrazolium compound.
28. In a method for detecting the presence of an analyte in a sample, the improvement comprising:
employing a signal producing system according to Claim 1.
employing a signal producing system according to Claim 1.
29. The method according to Claim 28, wherein said signal producing system is present as a reagent composition according to Claim 11.
30. The method according to Claim 29, wherein said reagent composition is present on a reagent test strip according to Claim 21.
31. A kit for use in detecting the presence of an analyte in a sample, said kit comprising:
a signal producing system according to Claim 1.
a signal producing system according to Claim 1.
32. The kit according to Claim 31, wherein said signal producing system is present as a reagent composition according to Claim 11.
33. The kit according to Claim 32, wherein said reagent composition is present on a reagent test strip according to Claim 21.
34. The kit according to Claim 31, wherein said kit further comprises a means for obtaining a physiological sample.
35. The kit according to Claim 34, wherein said means for obtaining a physiological sample is a lance.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53720300A | 2000-03-28 | 2000-03-28 | |
| US09/537,203 | 2000-03-28 | ||
| PCT/US2001/007619 WO2001073114A2 (en) | 2000-03-28 | 2001-03-08 | Reagents and methods for detecting a reduced cofactor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2404421A1 true CA2404421A1 (en) | 2001-10-04 |
Family
ID=24141653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002404421A Abandoned CA2404421A1 (en) | 2000-03-28 | 2001-03-08 | Reagent systems for detecting the presence of a reduced cofactor in a sample and methods for using the same |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1268849A2 (en) |
| JP (1) | JP2003528623A (en) |
| KR (1) | KR20020089412A (en) |
| CN (1) | CN1419604A (en) |
| AR (1) | AR027726A1 (en) |
| AU (1) | AU2001243542A1 (en) |
| CA (1) | CA2404421A1 (en) |
| HK (1) | HK1050030A1 (en) |
| IL (1) | IL151262A0 (en) |
| MX (1) | MXPA02009469A (en) |
| PL (1) | PL357180A1 (en) |
| RU (1) | RU2266543C2 (en) |
| WO (1) | WO2001073114A2 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050103624A1 (en) | 1999-10-04 | 2005-05-19 | Bhullar Raghbir S. | Biosensor and method of making |
| GB0204232D0 (en) * | 2002-02-22 | 2002-04-10 | Isis Innovation | Assay |
| US7452457B2 (en) | 2003-06-20 | 2008-11-18 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using dose sufficiency electrodes |
| US8148164B2 (en) | 2003-06-20 | 2012-04-03 | Roche Diagnostics Operations, Inc. | System and method for determining the concentration of an analyte in a sample fluid |
| US8071030B2 (en) | 2003-06-20 | 2011-12-06 | Roche Diagnostics Operations, Inc. | Test strip with flared sample receiving chamber |
| CN1846131B (en) | 2003-06-20 | 2012-01-18 | 霍夫曼-拉罗奇有限公司 | Method and reagent for producing narrow, homogenous reagent strips |
| US7569126B2 (en) | 2004-06-18 | 2009-08-04 | Roche Diagnostics Operations, Inc. | System and method for quality assurance of a biosensor test strip |
| ITMI20050881A1 (en) * | 2005-05-16 | 2006-11-17 | Anna Favre | DIAGNOSTIC KIT FOR HIRSCHSPRUNG MEGALON CONGENITAL DISEASE |
| DE102006002165A1 (en) * | 2006-01-17 | 2007-07-19 | Merck Patent Gmbh | Determining acetate content in a sample, comprises contacting a sample with test strip comprising e.g. tetrazolium salt, incubating the test strip, contacting test strip with phenazine methosulfate reagent and observing color change |
| EP2542887B1 (en) * | 2010-03-01 | 2013-06-19 | System Biologie AG | Test strip for the detection of equol |
| CN102520198A (en) * | 2011-11-21 | 2012-06-27 | 宁波美康生物科技股份有限公司 | Ethanol concentration detection kit and manufacture method thereof |
| CN102520150A (en) * | 2011-12-08 | 2012-06-27 | 上海高丰医疗电器有限公司 | Diagnostic test paper for determination of gamma-hydroxybutanoic acid and preparation method thereof |
| US8920628B2 (en) | 2012-11-02 | 2014-12-30 | Roche Diagnostics Operations, Inc. | Systems and methods for multiple analyte analysis |
| US8921061B2 (en) | 2012-11-02 | 2014-12-30 | Roche Diagnostics Operations, Inc. | Reagent materials and associated test elements |
| CN108359710B (en) * | 2018-02-11 | 2019-04-30 | 山东大学齐鲁医院 | The enzyme colour developing quantitative determination reagent kit and measuring method of glucosephosphate isomerase |
| CN110117791B (en) * | 2019-05-23 | 2023-11-10 | 电子科技大学 | Binding force promoter for brown oxide liquid of high-density interconnection printed circuit board |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3247894A1 (en) * | 1982-12-24 | 1984-06-28 | Merck Patent Gmbh, 6100 Darmstadt | TEST SYSTEM AND METHOD FOR DETERMINING NAD (P) H |
| JPS60180600A (en) * | 1984-02-29 | 1985-09-14 | Kyowa Medetsukusu Kk | Determination of reduced-type nicotinamide adenine dinucleotide |
| US5036000A (en) * | 1986-12-16 | 1991-07-30 | Enzymatics, Inc. | Threshold color control system |
| SE466158B (en) * | 1989-04-25 | 1992-01-07 | Migrata Uk Ltd | METHOD OF ANALYSIS FOR GLUCOSE DETERMINATION IN WHOLE BLOOD |
| US5902731A (en) * | 1998-09-28 | 1999-05-11 | Lifescan, Inc. | Diagnostics based on tetrazolium compounds |
-
2001
- 2001-03-08 IL IL15126201A patent/IL151262A0/en unknown
- 2001-03-08 RU RU2002123839/15A patent/RU2266543C2/en not_active IP Right Cessation
- 2001-03-08 WO PCT/US2001/007619 patent/WO2001073114A2/en not_active Application Discontinuation
- 2001-03-08 CA CA002404421A patent/CA2404421A1/en not_active Abandoned
- 2001-03-08 MX MXPA02009469A patent/MXPA02009469A/en unknown
- 2001-03-08 AU AU2001243542A patent/AU2001243542A1/en not_active Abandoned
- 2001-03-08 EP EP01916527A patent/EP1268849A2/en not_active Withdrawn
- 2001-03-08 PL PL01357180A patent/PL357180A1/en not_active Application Discontinuation
- 2001-03-08 KR KR1020027012698A patent/KR20020089412A/en not_active Application Discontinuation
- 2001-03-08 JP JP2001570828A patent/JP2003528623A/en active Pending
- 2001-03-08 CN CN01806937A patent/CN1419604A/en active Pending
- 2001-03-27 AR ARP010101443A patent/AR027726A1/en unknown
-
2003
- 2003-03-25 HK HK03102161.6A patent/HK1050030A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1050030A1 (en) | 2003-06-06 |
| WO2001073114A3 (en) | 2002-03-28 |
| KR20020089412A (en) | 2002-11-29 |
| WO2001073114A2 (en) | 2001-10-04 |
| JP2003528623A (en) | 2003-09-30 |
| AR027726A1 (en) | 2003-04-09 |
| RU2002123839A (en) | 2004-03-10 |
| CN1419604A (en) | 2003-05-21 |
| RU2266543C2 (en) | 2005-12-20 |
| EP1268849A2 (en) | 2003-01-02 |
| AU2001243542A1 (en) | 2001-10-08 |
| IL151262A0 (en) | 2003-04-10 |
| PL357180A1 (en) | 2004-07-26 |
| MXPA02009469A (en) | 2003-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6586199B2 (en) | Stabilized tetrazolium reagent compositions and methods for using the same | |
| EP1317563B1 (en) | Test-strips with positively charged membranes for tetrazolium based assays | |
| AU763065B2 (en) | Diagnostics based on tetrazolium compounds | |
| US6939685B2 (en) | Stabilized tetrazolium phenazine reagent compositions and methods for using the same | |
| AU628751B2 (en) | Composition and method of assaying for ketone bodies | |
| CA2404421A1 (en) | Reagent systems for detecting the presence of a reduced cofactor in a sample and methods for using the same | |
| AU2003207797A1 (en) | Method and test strips for the measurement of fat loss during weight loss programs | |
| US5510245A (en) | Composition and method of assaying for ketone bodies | |
| AU2001288935A2 (en) | Test-strips with positively charged membranes for tetrazolium based assays |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |